ALPHA TEKNOVA, INC. Inventory Write-down
ALPHA TEKNOVA, INC. (TKNO) reported Inventory Write-down of $825.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:InventoryWriteDown · last filed 2026-08-06
- ALPHA TEKNOVA, INC. inventory write-down for the quarter ending 2026-06-30 was $412.00K, a 15.57% decline year-over-year.
- ALPHA TEKNOVA, INC. inventory write-down for the quarter ending 2026-03-31 was $413.00K, a 5.49% decline year-over-year.
- ALPHA TEKNOVA, INC. inventory write-down for the quarter ending 2025-12-31 was $458.00K, a 45.86% increase year-over-year.
- ALPHA TEKNOVA, INC. inventory write-down for the quarter ending 2025-09-30 was $732.00K, a 78.08% decline year-over-year.
- ALPHA TEKNOVA, INC. inventory write-down for fiscal 2025 was $2.12M, a 53.51% decline from fiscal 2024.
- ALPHA TEKNOVA, INC. inventory write-down for fiscal 2024 was $4.55M, a 1308.36% increase from fiscal 2023.
- ALPHA TEKNOVA, INC. inventory write-down for fiscal 2023 was $323.00K, a 53.66% decline from fiscal 2022.
- ALPHA TEKNOVA, INC. inventory write-down for fiscal 2022 was $697.00K, a 58.05% increase from fiscal 2021.
| Period end | Inventory Write-down 3 month | Inventory Write-down 6 month | Inventory Write-down 9 month | Inventory Write-down 12 month |
|---|---|---|---|---|
| 2026-06-30 | $412.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $825.00K 10-Q · filed 2026-08-06 | $1.28M derived: sum of 3 quarters · filed 2026-08-06 | $2.02M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $413.00K 10-Q · filed 2026-05-07 | $871.00K derived: sum of 2 quarters · filed 2026-05-07 | $1.60M derived: sum of 3 quarters · filed 2026-05-07 | $2.09M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $458.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $1.19M derived: sum of 2 quarters · filed 2026-03-02 | $1.68M derived: sum of 3 quarters · filed 2026-08-06 | $2.12M 10-K · filed 2026-03-02 |
| 2025-09-30 | $732.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $1.22M derived: sum of 2 quarters · filed 2026-08-06 | $1.66M 10-Q · filed 2025-11-07 | $1.97M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $488.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $925.00K 10-Q · filed 2026-08-06 | $1.24M derived: sum of 3 quarters · filed 2026-08-06 | $4.58M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $437.00K 10-Q · filed 2026-05-07 | $751.00K derived: sum of 2 quarters · filed 2026-05-07 | $4.09M derived: sum of 3 quarters · filed 2026-05-07 | $5.08M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $314.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $3.65M derived: sum of 2 quarters · filed 2026-03-02 | $4.64M derived: sum of 3 quarters · filed 2026-03-02 | $4.55M 10-K · filed 2026-03-02 |
| 2024-09-30 | $3.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $4.33M derived: sum of 2 quarters · filed 2025-11-07 | $4.24M 10-Q · filed 2025-11-07 | $4.43M derived: sum of 4 quarters · filed 2025-11-07 |
| 2024-06-30 | $987.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $896.00K 10-Q · filed 2025-08-08 | $1.09M derived: sum of 3 quarters · filed 2025-08-08 | $1.19M derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | -$91.00K 10-Q · filed 2025-05-09 | $102.00K derived: sum of 2 quarters · filed 2025-05-09 | $199.00K derived: sum of 3 quarters · filed 2025-05-09 | $376.00K derived: sum of 4 quarters · filed 2025-05-09 |
| 2023-12-31 | $193.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | $290.00K derived: sum of 2 quarters · filed 2025-03-07 | $467.00K derived: sum of 3 quarters · filed 2025-03-07 | $323.00K 10-K · filed 2025-03-07 |
| 2023-09-30 | $97.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $274.00K derived: sum of 2 quarters · filed 2024-11-08 | $130.00K 10-Q · filed 2024-11-08 | $649.00K derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | $177.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $33.00K 10-Q · filed 2024-08-13 | $552.00K derived: sum of 3 quarters · filed 2024-08-13 | $738.00K derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | -$144.00K 10-Q · filed 2024-05-13 | $375.00K derived: sum of 2 quarters · filed 2024-05-13 | $561.00K derived: sum of 3 quarters · filed 2024-05-13 | $557.00K derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | $519.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $705.00K derived: sum of 2 quarters · filed 2024-03-27 | $701.00K derived: sum of 3 quarters · filed 2024-03-27 | $697.00K 10-K · filed 2024-03-27 |
| 2022-09-30 | $186.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $182.00K derived: sum of 2 quarters · filed 2023-11-13 | $178.00K 10-Q · filed 2023-11-13 | -$57.00K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | -$4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | -$8.00K 10-Q · filed 2023-08-11 | -$243.00K derived: sum of 3 quarters · filed 2023-08-11 | -$266.00K derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | -$4.00K 10-Q · filed 2023-05-11 | -$239.00K derived: sum of 2 quarters · filed 2023-05-11 | -$262.00K derived: sum of 3 quarters · filed 2023-05-11 | $439.00K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | -$235.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$258.00K derived: sum of 2 quarters · filed 2023-03-30 | $443.00K derived: sum of 3 quarters · filed 2023-03-30 | $441.00K 10-K · filed 2023-03-30 |
| 2021-09-30 | -$23.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $678.00K derived: sum of 2 quarters · filed 2022-11-14 | $676.00K 10-Q · filed 2022-11-14 | $637.00K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $701.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $699.00K 10-Q · filed 2022-08-11 | $660.00K derived: sum of 3 quarters · filed 2022-08-11 | $669.00K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | -$2.00K 10-Q · filed 2022-05-12 | -$41.00K derived: sum of 2 quarters · filed 2022-05-12 | -$32.00K derived: sum of 3 quarters · filed 2022-05-12 | |
| 2020-12-31 | -$39.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-18 | -$30.00K derived: sum of 2 quarters · filed 2022-03-18 | -$29.00K 10-K · filed 2022-03-18 | |
| 2020-09-30 | $9.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $10.00K 10-Q · filed 2021-11-12 | ||
| 2020-06-30 | $1.00K 10-Q · filed 2021-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |